A Cognitive Behavioral Stress Intervention for Women Who Smoke
1 other identifier
interventional
70
1 country
1
Brief Summary
- 1.PURPOSE OF THE STUDY 1.1 Justification The purpose of the project is to examine the effect of breathing biofeedback and thoughts about stress on performance under stress and cigarette cravings. Smoking rates in the United States have been steadily going down over the past 50 years, and now 16.8% of adults smoke (Centers for Disease Control and Prevention, 2015). Most smokers try to quit, but end up going back to smoking (Garcia-Rodriguez et al., 2013; Piasecki, 2006; Rafful et al., 2013). The reasons people go back to smoking may have something to do with stress in their lives, particularly for women who smoke. This study wants to see if we can reduce temporary stress and lower craving to smoke after stress.
- 2.PROGRESSION OF THIS STUDY 2.1 Procedures The study visit procedures will take place at the Emotion and Psychopathology Laboratory at Rutgers University, located at the Rutgers Institute for Health, Healthcare Policy, and Aging Research. Participants will first complete some questionnaires and provide some basic information about themselves (demographic information, responses to emotion and stress, and smoking history). Next, participants will engage in a baseline psychophysiological assessment where investigators will examine heart rate, breathing, and blood pressure. Next, investigators will either ask participants to sit quietly for 30 minutes while completing a computer task and watching short videos, or practice a specific deep breathing exercise for 30 minutes. Then participants will do three tasks on a computer. The tasks will ask participants to trace different shapes, answer math problems while receiving feedback about how they're doing, and identify colors and words on a screen. Finally, participants will be asked to sit quietly for 15 minutes before investigators remove the psychophysiological recording equipment. One week after the study visit, investigators will contact participants via phone to ask them some questions about the study visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 22, 2017
CompletedFirst Posted
Study publicly available on registry
March 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2017
CompletedMarch 14, 2018
March 1, 2018
6 months
February 22, 2017
March 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in cigarette craving
Change in self-reported craving to smoke a cigarette as reported in the Questionnaire on Smoking Urges - Brief (QSU-B).
Total time frame of measurement is 3 hours. The QSU-B will be completed at T=0, T=25, T=75, T=90
Change in heart rate variability
Change in heart rate variability over the course of the study, as recorded on Biopac Acqknowledge software
3 hours
Performance on a stress task
Performance on the color-word Stroop task
10-15 minutes
Secondary Outcomes (1)
Changes in smoking behavior at follow-up
followup phone calls take place one week after the study visit
Study Arms (2)
Intervention Condition
EXPERIMENTALThis group will receive the heart rate variability biofeedback intervention in addition to the cognitive reappraisal of stress intervention
Control Condition
PLACEBO COMPARATORThis group will complete control tasks, including viewing neutral videos.
Interventions
Eligibility Criteria
You may qualify if:
- To be included in the study, participants must report smoking at least 10 cigarettes per day, and agree to complete study procedures, which requires a willingness to practice quitting smoking.
- They must also provide a breath carbon monoxide sample of at least 15ppm to verify their smoking status.
You may not qualify if:
- Color-blindness
- Current psychosis, current substance dependence, current body mass index (BMI) of over 40
- Current diagnosis of a cardiac rhythm abnormality (mitrovalve prolapse, frequent premature ventricular contractions
- Atrial fibrillation, bundle branch block) or a major neurological problem, history of a myocardial infarction, or past-week use of illicit drugs
- Nicotine replacement therapy, bupropion, varenicline, anti-cholinergic medications, beta blockers, Ritalin
- Benzodiazepines
- Tricyclic antidepressants
- Antipsychotic medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Health, Health Care Policy and Aging Research
New Brunswick, New Jersey, 08901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yasmine Omar, M.S.
Rutgers, The State University of New Jersey
- PRINCIPAL INVESTIGATOR
Edward Selby, Ph.D.
Rutgers, The State University of New Jersey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychology PhD Candidate
Study Record Dates
First Submitted
February 22, 2017
First Posted
March 13, 2017
Study Start
December 1, 2016
Primary Completion
May 30, 2017
Study Completion
May 30, 2017
Last Updated
March 14, 2018
Record last verified: 2018-03